Else Nutrition Holdings Inc.
BABYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | 0.90 | -0.04 | 7.25 |
| FCF Yield | -31.78% | -6.93% | -3.49% | -1.45% |
| EV / EBITDA | -1.99 | -17.60 | -34.68 | -62.68 |
| Quality | ||||
| ROIC | -559.79% | -104.63% | -81.01% | -56.44% |
| Gross Margin | -14.57% | -0.91% | 15.37% | 15.85% |
| Cash Conversion Ratio | 0.60 | 1.17 | 1.19 | 9.74 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.21% | 25.93% | 79.19% | 103.76% |
| Free Cash Flow Growth | 50.19% | 13.10% | -31.28% | -63.49% |
| Safety | ||||
| Net Debt / EBITDA | -0.05 | -0.17 | 0.60 | 1.28 |
| Interest Coverage | -216.43 | -257.92 | -1,496.38 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.78 | 1.30 | 1.22 | 0.87 |
| Cash Conversion Cycle | 141.19 | 272.75 | 253.72 | 307.28 |